Acurx Pharmaceuticals (ACXP) Change in Cash (2020 - 2026)
Acurx Pharmaceuticals' (ACXP) quarterly Change in Cash came in at $1.7 million in Q1 2026, up 81.26% YoY from $937174.0 in Q1 2025, and up 3.0% on a QoQ basis from $1.6 million in Q4 2025.
Acurx Pharmaceuticals (ACXP) Change in Cash (2020 - 2026) Analysis & Trends
Acurx Pharmaceuticals (ACXP) has 7 years of Change in Cash data on file, last reported at $1.7 million in Q1 2026.
- Quarterly Change in Cash rose 81.26% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.6 million (up 207.81% YoY) and the FY2025 annual result came in at $3.8 million, up 202.17% from the prior year.
- Change in Cash grew to $1.7 million in Q1 2026, from $1.6 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $2.0 million in Q2 2023 to a low of -$2.6 million in Q2 2024.
- A 5-year average of -$217884.3 and a median of -$157326.0 in 2025 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2023 — Change in Cash surged 198.81% — and 2024, when it sank 587.33%.
- Tracing ACXP's Change in Cash over 5 years: stood at -$1.5 million in 2022, then soared by 128.21% to $421859.0 in 2023, then slumped by 587.33% to -$2.1 million in 2024, then jumped by 180.22% to $1.6 million in 2025, then climbed by 3.0% to $1.7 million in 2026.
- The last three Change in Cash figures came in at $1.7 million (Q1 2026), $1.6 million (Q4 2025), and -$157326.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Acurx Pharmaceuticals | 6.38 Mn | 6.38 Mn | - | 1.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.40 Mn |
| Mar 31, 2026 | 1.70 Mn |
| Dec 31, 2025 | 1.65 Mn |
| Sep 30, 2025 | -157,326.00 |
| Jun 30, 2025 | 1.42 Mn |
| Mar 31, 2025 | 937,174.00 |
| Dec 31, 2024 | -2.06 Mn |
| Sep 30, 2024 | -598,294.00 |
| Jun 30, 2024 | -2.56 Mn |
| Mar 31, 2024 | 1.45 Mn |
| Dec 31, 2023 | 421,859.00 |
| Sep 30, 2023 | -2.09 Mn |
| Jun 30, 2023 | 1.97 Mn |
| Mar 31, 2023 | -1.93 Mn |
| Dec 31, 2022 | -1.50 Mn |
| Sep 30, 2022 | 1.52 Mn |
| Jun 30, 2022 | -1.99 Mn |
| Mar 31, 2022 | -1.88 Mn |
| Dec 31, 2021 | -1.50 Mn |
| Sep 30, 2021 | -2.64 Mn |